Evidence map›Paper›PMID 42866950›Full record

ArticleNucleic acids research2026

PXL: a nucleic acid-binding module of the promyelocytic leukemia protein.

Daniel Fairchild, Irina V Semenova, Dane Geddes-Buehre, Yunfeng Li, Renata Szczepaniak, Sandra K Weller, Bing Hao, Irina Bezsonova

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daniel FairchildDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.ORCID 0000-0001-9191-1149
Irina V SemenovaDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.
Dane Geddes-BuehreDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.
Yunfeng LiDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.
Renata SzczepaniakDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.
Sandra K WellerDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.
Bing HaoDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.ORCID 0000-0003-3029-5340
Irina BezsonovaDepartment of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.ORCID 0000-0002-8629-0349

Funding

UBIQUITIN-PROTEASOME PATHWAY in HUMAN DISEASER35GM156397 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Irina Bezsonova · 2025 to 2026
$1000k
Oxidation is a trigger for PML multimerization and Nuclear Body formation in HSV infected cellsR21AI135451 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BEZSONOVA, IRINA, WELLER, SANDRA K · 2018 to 2019
$433k
NIAID NIH HHS R21 AI135451NIAID NIH HHS R21AI135451NIGMS NIH HHS R35 GM156397NIGMS NIH HHS R35GM156397
6 · The paper itself

Abstract

The promyelocytic leukemia protein (PML) is a stress-response factor that assembles into PML nuclear bodies, dynamic subnuclear compartments involved in tumor suppression and antiviral defense. The most abundant isoform, PML-1, has been linked to transcriptional regulation, genome stability, and antiviral responses, yet the molecular basis of these functions remains unclear and is generally attributed to proteins associated with PML nuclear bodies. Here, we report that PML-1 itself harbors a previously structurally uncharacterized nucleic acid-binding domain. The domain, termed PXL, is encoded by exon 9 of the PML gene and is unique to isoform 1. Its structure reveals an exonuclease III fold, but lacks the catalytic residues required for activity, defining PXL as a pseudo-exonuclease. Biochemical, structural, mutational, and cellular analyses demonstrate that PXL specifically binds G-rich oligonucleotides implicated in G-quadruplex formation and displays a strong in vitro preference for polyUG RNA. Furthermore, deletion of the PXL domain significantly decreases PML colocalization with G-quadruplexes in cells, downregulates genomic maintenance pathways, and modulates the expression of E2F target and interferon-α response genes. These findings provide a molecular basis for previous observations implicating PML in nucleic acid-associated functions and establish a mechanistic framework for future studies of PML-mediated stress responses, nuclear organization, and gene regulation.

Indexed as

Promyelocytic Leukemia ProteinExodeoxyribonucleasesG-QuadruplexesHumansProtein BindingProtein DomainsProtein Isoformsexodeoxyribonuclease IIIExodeoxyribonucleasesPML protein, humanPromyelocytic Leukemia ProteinProtein Isoforms

Identifiers

PMID42866950
PMCPMC13659232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.